CURRENT PERSONNEL
PAST LAB MEMBERS
AMBER JOHNSON, PHD
Postdoctoral Fellow
Amber's research goal is to investigate the immunosuppressive mechanisms in the tumor microenvironment in lung cancer. In her post-doctoral work she combines the strengths of in vivo models and in vitro models to investigate how myofibroblasts influence the tumor microenvironment. Check out her latest publication here.
Graduate Students
Emily Wagner, MS, Biomedical Sciences; Inscripta
Bonnie Bullock, PhD, Cancer Biology; Vaniam Group
Jeff Kwak, PhD, Cancer Biology; Fred Hutchinson Cancer Research Center
Alison Ostriker, PhD, Pharmacology; Yale University, Cardiovascular Medicine
Stacy Blaine, PhD, Pharmacology; Advanced Clinical Pharmaceuticals
​
Post-Doctoral Researchers
Trisha Berger, PhD; The Med Writers
​
Medical Fellows
Howard Li, MD; Virginia Commonwealth University, Division of Pulmonary Disease and Critical Care Medicine
Alex Neuwelt, MD; Virginia Commonwealth University, Division of Hematology, Oncology & Palliative Care
Seth Ferguson, MD; University of Colorado, Division of Renal Disease and Hypertension
John Montford, MD; University of Colorado, Division of Renal Diseases and Hypertension
​
​
EMILY KLECKZO, PHD
Research Instructor
Emily is the lead investigator on the Complement Project, using her expertise in cancer biology, cell signaling, and immunology to investigate the role of the innate immune complement pathway on the progression of lung cancer. Check out her latest publication here.